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Introduction
Despite McKhann et al. [1] and DSM IV [2] diagnostic
criteria, differentiating early Alzheimer dementia (AD)
from cognitive changes occurring in other non-dementing
conditions such as physiological aging or depressive
pseudodementia of the elderly may present some difficul-
ties. Moreover, diagnostic criteria have not been clearly
defined in other degenerative dementia of non-AD type,
i.e. Pick’s disease, frontal degeneration and dementia with
Lewy’s bodies. Biological markers in vivo of AD have, in
fact, not yet been identified.
A disturbance of memory is frequently the first symp-
tom of complaint in AD patients and is generally regarded
as a necessary (but not a sufficient) clinical feature for the
diagnosis [1, 2]. Despite controversy about which struc-
tures are critical for normal processes, it is widely ac-
cepted that brain damage in amnesic subjects involves the
mesial temporal areas and/or portions of the dien-
cephalon. Among these areas, the most consistently and
extensively damaged in AD are the mesial temporal struc-
tures [3]. Volumetric measurements by magnetic reso-
nance imaging (MRI) of the temporal lobe, amygdala and
hippocampal formation have therefore been proposed
[4–7]. MRI studies have confirmed the reduction of tem-
poral lobe and hippocampal structures in AD [8–10],
while in normal subjects a significant age-related decrease
only of the frontal lobe, but not of the temporal one, has
been found [11]. The degree of volume reduction seem to
be related to disease progression.
The aim of this study was therefore to evaluate: (a) any
correlation between volumetric measurements and neu-
ropsychological parameters and (b) whether such correla-
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tions were specific for AD and could improve the diagnos-
tic accuracy in the early stages of the disease. The cognitive
evaluation, unlike other studies that have employed rough
neuropsychological measures, has been aimed to accurately
investigate specific aspects of declarative memory function.
Patients and methods
Patients
Thirty-one patients with a diagnosis of probable AD according to
NINCDS-ADRDA [1] criteria and mild to moderate severity
[Global Deterioration Scale (GDS) = 4–5; Mini Mental State
(MMS) ranged from 14 to 23] [12, 13] were recruited.
No vascular risk factors or symptomatic vascular disease (heart
disease, stroke or TIA, history of syncope, focal neurological
signs, symptomatic orthostatic hypotension) were detected
[Hachinski Ischaemic Score (HIS) 4] [14]. Severe neuropsychi-
atric disorders and the use of neuroleptics were also exclusion cri-
teria. The Barthel index was used as a measure of functional dis-
ability [15]. We studied all cases consecutively observed at the
Neurological Institute C. Mondino during 1996. Neurological,
neuropsychological and neuroradiological investigations were car-
ried out. MRI was performed in the same week as the neuropsy-
chological evaluation.
Twenty-two subjects were selected as a control group. Their
distribution for decades, sex and education was similar to the AD
group. Controls were recruited from inpatients referred to our neu-
rological institute for neurological disorders not involving the cen-
tral nervous system such as peripheral nerve entrapment, lum-
bosacral pain or sciatica. None had a history of head trauma, alco-
hol abuse or symptomatic vascular disease. No previous central
neurological or psychiatric diseases were detected. The MMS
score was > 24 and the neurological examination excluded central
signs. All patients and controls were right-handed according to the
Oldfield questionnaire [16]. Informed consent was obtained by
each subject included in the study.
Methods
Neuroradiological investigation
MRI was performed with a 0.5-T superconducting magnet (Philips
Gyroscan T5). Sagittal T1-weighted images (SE, 5 mm thick, 
2.5 mm gap, TR 520, TE 20, NSA 1) and T2-weighted scans (SE,
7 mm thick, 0.7 mm gap, TE 2500, TE 40/100, NSA 1) were first
obtained to determine the long axis of the temporal lobe and to ex-
clude major cerebral infarction (Fig.1). A sequence of 128 coronal
oblique T1-weighted fast-field-echo images perpendicular to the
long axis of the temporal lobe was performed to measure the vol-
ume of brain, temporal lobe and amygdala (TR 33, TE 13, FA 30,
1.5 mm thick, overcontiguous, NSA 2).
Image processing: The images were transferred to a SUN Gy-
roview-HR workstation and analsed with a CAMRA S400 Allegro
application by ISG Technology Inc. through three steps:
1. Identification and storage of window width and level
2. Segmentation techniques that include region-growing from
seed point to isolate objects of similar intensities and gradient-
based edge-tracking for complex contours
3. Automatic volumetric reconstruction
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Fig.1 Sagittal T1-weighted image for the determination of the
long axis of the temporal lobe
Fig.2A, B Three-dimensional reconstruction of the brain: (A) lat-
eral view, (B) temporal lobes, axial view
A
B
Brain temporal lobes and amygdala, except brain stem and cere-
bellum, were reconstructed (Fig. 2A, B). The posterior boundary
for the temporal lobes was defined by the oblique coronal plane in-
tersecting the posterior commissure and the anterior boundary by
the most anterior slice of the temporal lobe. The anatomical guide-
lines for the amygdala were fixed according to a temporal lobe an-
tomy atlas (Fig.3) [17].
Volumes were measured in cubic centimetres as absulute vol-
ume, and for the temporal lobes and amygdala also as percentage
of total brain volume in order to minimize the effect of interindi-
vidual variation in head size. For temporal lobe and amygdala, the
volume is the sum of both sides.
Measurements were performed separately by two operators ex-
perienced in the procedure and blinded to clinical and neuropsy-
chological information. In order to evaluate the reproducibility of
the volume measurements, a second evalutaion was performed af-
ter 1 month. The correlation coefficient between the two readings
ranged from 0.92 to 0.97 for all measurement, indicating a good
level of reliability. We used the mean of the two volumetric mea-
surements in the final analysis. The extent of high signal lesions
(HSL) such as subcortical white matter lesions (WML) and
periventricular hyperintensities (PHV) was also recorded. Ratings,
based on the proton density images, of PVH were made on a four
point scale: 0 = absent, 1 = pencil-thin lining or “caps” at the tips
of lateral ventricles, 2 = thick lining, 4 = large confluence around
the ventricles extending throughout the centrum semiovale with ir-
regular edges [18].
Neuropsychological assessment
The neuropsychological tests, given to all AD patients, are listed
below. Cut-off scores for tests were set to the 5th centile of normal
population scores, adjusted for age, education and, when appropri-
ate, sex [19, 20]. All of the tests were performed by two trained
neuropsychologists:
1. Short-term memory
a) Word Span (verbal): Corsi’s Block Tapping Test (visuo-spa-
tial [19]
b) Visual memory: Immediate Visual Memory Test (IVM)
(recognition) [21]
2. Long-term explicit memory
a) Episodic: Rey’s 15 words (verbal learning and delayed re-
call) [21]
Visuo-spatial supra-span learning Corsi’s Block Tapping
Test [19]
b) Semantic: The vocabulary subtest from the Italian version of
the Wechsler Adult Intelligence Scale (WAIS) [22]
3. Verbal attainments
a) Word fluency (FAS) [21]
b) Phrase construction [21]
4. Visuo-spatial intelligence
Raven’s coloured progressive matrices (PM) [21]
5. Constructive functions
Copying design: simple copy (SC) and with landmarks [21]
Statistical analysis
The demographic, volumetric and neuropsychological measures
were compared using the Mann-Whitney U test and the chi-square
test. Simple regression analyses (r) were performed between age,
psychometric performances (corrected scores) and volumetric
measures. Statistical significance was taken at P < 0.05.
Results
Table 1 summarises the main demographic characteristics.
The two groups, AD and controls, did not significantly
differ in age, sex, distribution and education.
Alzheimer patients showed significant reduction in
volumetric measurements compared with controls consid-
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Fig. 3 Boundaries of the amygdala determined on magnetic reso-
nance imaging coronal oblique slice
Table 1 Demographic variables of AD patients and control group
(AD Alzheimer dementia, MMS Mini Mental State, GDS Global
Deterioration Scale)
AD Controls
n 31 22
Sex (M/F) 13/18 10/12
Age (years) (SD) 68 (6.8) 67.7 (7.9)
(58–82) (55–80)
Education (years) (SD) 7.5 (2.4) 7.8 (3.2)
(5–13) (5–13)
MMS (SD) 17.2 (3.2) 28.8 (1.1)
(14–23) (25–30)
Arterial hypertension 5 3
Ischaemic score (SD) 1.3 (0.5) –
(0–3)
Degree of dementia (GDS) –
Mild 17
Moderate 14
Duration of dementia (months) (SD) 25 (8) –
(8–35)
ering the total volume, temporal lobe (P < 0.05) and
amygdala (P < 0.05) (Fig.4). The temporal lobe/brain vol-
ume ratio was also significantly reduced in AD subjects
(P < 0.05) (Table 2). AD patients had greater atrophy than
controls for all measurements but, with respect to age, the
slope of regression was not different between patients and
controls (total volume: AD r = 20, controls r = 18; tem-
poral lobe: AD r = 25, control r = 21).
PVH scores were equal to 0–1 in 19/31 AD patients
(61%) to 2 in 12/31 subjects (39%). The presence of mild
to moderate WML was significantly associated with
PVH: 7/12 patients (58%) with grade 2 PVH and WML
compared with only 3/19 patients (15%) with less promi-
nent PVH (chi-square test P < 0.05). In 5/22 control sub-
jects (23%), a PVH score equal to 2 was also detectable
(chi-square test not significant vs AD).
Neuropsychological performances of AD are shown in
Table 3. Several cognitive areas were affected, in particu-
lar long-term episodic and semantic memory.
No significant difference among demographic vari-
ables, functional disability, volumetric measurement and
cognitive dysfunction was detectable between the two
PVH groups (Tables 2, 3).
Finally, volumetric variables of 31 AD patients were
compared with their cognitive performances. The analysis
revealed a significant correlation between temporal lobe
atrophy and degree of memory impairment: Rey’s 15
words (verbal learning r = 56, P < 0.01; delayed recall r =
47, P < 0.01 and WAIS vocabulary (r = 51, P < 0.01) with
left temporal lobe, visuo-spatial supra-span learning with
right temporal lobe (r = 42, P < 0.05). No significant cor-
relations were found between memory measures and
amygdala volume.
Discussion
The neuropathological changes of AD involve several
cortical and subcortical structures characterised by diffuse
neuronal loss, senile plaques and neurofibrillary tangles.
Such pervasive damage is responsible for the various cog-
nitive deficits exhibited by AD patients. The mesial tem-
poral structures are severly compromised, and most of the
neurons that normally make wide connections between
the hippocampus and multiple cortical and subcortical ar-
eas are affected [23].
The abnormalities of temporal lobes and hippocampus
can be related to pervasive deficits of explicit memory,
which is one of the hallmarks of the disease, especially in
the early stages. Memory in fact is not a unitary function,
but consists of several different interacting systems sub-
served by different anatomical regions [24, 25]. In our
study, we investigated short-term and long-term memory,
which in turn includes episodic and semantic memory.
Measures for each memory subsystem were administered
and material-specific effects (verbal/visuo-spatial) were
also considered.
The results of this study confirm, using MRI volumet-
ric measurements, the involvement of temporal structures
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Table 2 Volumetric magnetic
resonance imaging analysis
(cubic centimetres) in AD pa-
tients (PVH+ and PVH–) and
controls [mean (SD)] (PVH
periventricular hypertensities,
BV brain volume)
*P < 0.05, **P < 0.01 (AD vs
controls)
AD PVH– PVH+ Controls
(n = 31) (n = 19) (n = 12) (n = 22)
BV 826 (59.8)** 821 (39) 829 (55) 922 (46.3)
Temporal lobe 104 (16.5)** 101 (14.0) 106 (13.1) 125 (13.4)
Left 54.2 (9.0)** 53.1 (7.8) 54.5 (8.5) 64.3 (9.1)
Right 49.8 (8.8)** 48.4 (9.0) 51.6 (8.1) 60.8 (8.2)
Temporal lobe/BV 12.5 (1.7)* 12.3 (1.5) 1.27 (1.6) 13.8 (1.9)
Amygdala 1.23 (0.4)* 1.22 (0.4) 1.25 (0.3) 1.45 (0.3)
Amygdala/BV 0.15 (0.06) 0.16 (0.05) 0.15 (0.04) 0.16 (0.05)
Fig.4 Coronal T1-weighted images of the temporal lobes: severe
temporal lobe atrophy in a patient with Alzheimer dementia
and amygdala by comparing a selected group of early im-
paired AD patients with control subjects. The reduction of
temporal lobe/brain volume ratio in AD patients supports
the hypothesis that this measure is able to discriminate
much more powerfully than an estimate of overall brain
atrophy. Moreover, regression analysis indicated that vol-
ume loss with age was not different between the two
groups.
Selective atrophy of the temporal lobes appears to be
related in our patients with the degree of memory impair-
ment. In fact, significant correlation between temporal
lobes and memory measures were found; verbal learning
and semantic memory deficits were related to left tempo-
ral lobe atrophy, right temporal involvement was sensible
to impairment of long-term visuo-spatial memory. Mem-
ory impairment was not related to amygdala involvement.
Deweer et al. [10] also did not find any correlation be-
tween anygdala volume and memory index. The authors
suggested, on the basis of animal experience, that amyg-
dala damage alone does not impair memory.
The results of our study confirm that temporal lobe at-
rophy assessed with MRI could be of diagnostic value in
AD, especially in the early stages of the disease. Follow-
up studies are needed to document the temporal evolution
of structural changes in relation to the rate of cognitive
decline.
In about the 40% of our AD patients and 23% of the
control group, periventricular high signal areas were de-
tected. The pathophysiology and clinical relevance of
these findings in AD remain controversial. In our popula-
tion, these lesions were not related to volumetric mea-
surements, severity of dementia or functional disability.
The two groups in fact did not show a different pattern of
cognitive involvement. According to previous data [18],
the incidence of these abnormalities, if age and vascular
risk factors are excluded, did not significantly differ from
control patients, and their presence should not be used to
preclude a diagnosis of AD.
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Table 3 Neuropsychological
measures in AD patients (IVM
immediate visual memory test,
WAIS Wechsler Adult Intelli-
gence Scale, SC single copy,
CL copy with landmarks)
AD score Lower limit AD PVH– PVH+
[mean (SD)] of tolerance (n = 31) (n = 19) (n = 12)
interval
[Patients impaired (n)]
Word span 3.7 (0.8) 3 3 2 1
Corsi span 3.8 (1.0) 3.75 9 5 4
Corsi supra-span 2.1 (3.7) 5.75 29 17 12
IVM 14.5 (2.8) 13.85 10 6 4
Rey’s 15 words
Learning 16 (5.6) 28.53 30 18 12
Recall 1.1 (2) 4.69 28 17 11
WAIS vocabulary 30.1 (15.6) 18 18 10 8
Word fluency 9.4 (3.4) 17.35 15 9 6
Phrase construction 7.9 (2.3) 8.72 12 7 5
Raven’s matrices 15.1 (4.6) 18.96 13 8 5
Copying design
SC 6.7 (1.2) 7.18 15 9 6
CL 60.2 (2.7) 61.85 13 8 5
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